SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as investors discuss Goldman Sachs taking a 5% stake, viewing it as a strong bullish signal and potential catalyst for a significant price increase. The community is also focused on upcoming tradable warrants, anticipating a short squeeze and further upward momentum. Talk centers around the company's potential for growth in the real estate market and a possible turnaround.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending, with community members pointing to a potential short squeeze and bargain prices, despite concerns about company leadership and recent performance. Some investors express frustration with the stock's behavior, while others remain optimistic, citing the company's cash reserves and potential for future growth. Discussions include mentions of a "discord grifter", and references to a potential catalyst.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending due to community discussion around the potential acquisition of Northern Data and positive impacts from Tether's investments, including ad spending and GPU commitments. Community members are weighing the significance of Rumble's AI and cloud infrastructure growth and speculating about a possible short squeeze. Some investors are expressing concern about the current stock performance in light of upcoming earnings.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano is trending following news of a Nasdaq extension for compliance, sparking significant community interest and trading volume. Traders are actively discussing potential price movements, short squeezes, and comparing it to other recent high-flying low float stocks like $GLTO. The stock's volatility and potential for further gains are key talking points.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to discussions around its low float and potential for a short squeeze, with some traders drawing comparisons to previous runners like $MOVE. Community chatter highlights the high cost to borrow and speculation about a significant move, while others express skepticism and caution due to recent volatility. The stock's potential is being debated, with focus on technical indicators and upcoming events.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending as investors await Phase 3 trial data, with community discussions focused on potential outcomes and the company's future. Optimism is fueled by analyst ratings and prior trial results, while concerns linger around the timing of data release and potential price manipulation by shorts. The stock's volatility reflects the high stakes riding on the upcoming data.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending as the company's pension transfer nears completion, potentially freeing up significant cash and resolving going concern issues. The community is discussing the possibility of a meme-driven short squeeze, drawing parallels to previous rallies and highlighting the stock's undervalued status. Some are anticipating news related to the company's expansion into pharmaceuticals and advanced materials.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors discuss the upcoming CHMP opinion on Blarcamesine, its Alzheimer's drug, with community members weighing approval prospects and potential market impact. Despite recent price drops, some believe a positive opinion could trigger a significant short squeeze, while others highlight the potential for a precision medicine approach. Discussions also include potential partnerships and buyout scenarios following the regulatory decision.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan Green in 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

LYFT is trending amid community discussion of solid earnings and potential takeover speculation, with some traders pointing to bullish technical patterns. Community members are debating driver compensation, service quality compared to competitors, and the potential impact of autonomous vehicle partnerships. Analyst ratings are being closely watched as some firms update their price targets.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

AQST is trending as investors discuss the potential impact of a competitor's earnings report and institutional ownership updates. Community members are weighing the significance of SPRY's results on AQST's future, while also considering the upcoming PDUFA date and the possibility of a partnership or acquisition. Bullish sentiment remains due to the company's technology and potential, though some express concerns about market penetration and the overall market's influence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


aa888betus

Link Vào AA88 Uy Tín